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Abstract--Three 6-thioguanine-resistant mutants of  the human diploid 
lymphoblast line MGL-8 were studied. The inactivation by heat of both 
HGPRT activity and antigenicity of the HGPRT immunologically cross- 
reacting material of the A30 mutant cells were not protected by PRPP, 
indicating that the HGPRT in A30 cells has an altered PRPP binding site, 
leading to lack of stabilization and rapid degradation of the enzyme. Two 
dimensional separations of the immunoprecipitates from extracts of the 
parental and mutant cell lines showed that the A35 mutant CRM has a more 
acidic isoelectric pH, while the A30 CRM has a more basic isoelectric pH 
and that the A30 protein has a faster rate of degradation than the wild-type 
HGPRT. The A30 CRM also has a smaller molecular size than the 
wild-type enzyme. 
INTRODUCTION 
We have previously described a series of independent 6-thioguanine 
(6-TG) resistant mutants derived from a mutagen-treated diploid human 
lymphoblast cell line. Four of these variants had detectable amounts of 
immunologically cross-reacting material (CRM) to HGPRT (EC 2.4.2.8, 
IMP: pyrophosphate phosphoribosyltransferase). Of these, only mutant A30 
had significant residual enzyme activity. This was different from the normal 
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enzyme activity in its Km for PRPP and in its pH (10-7.4) activity ratio. Also, 
the enzyme activity present in extracts of A30 cells was much more sensitive 
to inactivation by heat and to degradation by trypsin than the wild-type 
enzyme (1). 
We have studied further three mutants in order to gain better under- 
standing of the nature of the changes resulting in cells with such a phenotype. 
The results of these studies indicate that the HGPRT in A30 cells has an 
altered PRPP binding site leading to lack of stabilization and rapid degrada- 
tion of the enzyme. Also, the A30 enzyme appears to be 3-9 amino acids 
shorter than the wild-type protein, perhaps representing a protein chain- 
termination mutation. 
MATERIALS AND METHODS 
Materials. Rabbit and goat antisera against human HGPRT were 
prepared and characterized as described elsewhere (2, 3). Rabbit anti-goat 
gammaglobulin antiserum was purchased from Antibodies, Inc., Davis, 
California. [8-t4C]Hypoxanthine (48.6 mCi/mmol) and [8-~4C]adenine (6.5 
mCi/mmol) were purchased from Amersham, and [35S]methionine (1.2 
Ci/mmol) from Schwartz-Mann. Tissue culture media were products of 
GIBCO, and irradiated fetal calf serum was obtained from Microbiological 
Associates. 
Cells. The human lymphoblast cell line MGL8 was established by Dr. 
H.R. Zielke. Selection and characterization of the 6-TG-resistant mutants 
A29, A30, and A35 have been described (1). To ensure the phenotypic 
stability of the mutant lines, duplicate cultures were tested for resistance to 
6-thioguanine (6-TG) and sensitivity to HAT medium (4, 5). 
Enzyme Assays. Logarithmically growing cells were washed twice in 
PBS, resuspended in 50 mM potassium phosphate buffer, pH 7.4, and lysed 
by freeze-thawing twice in a dry ice-ethanol bath. HGPRT activity was 
measured in a 24,000g supernatant. Conditions for the HGPRT assay as well 
as for the determination of CRM by the immunoprecipitation inhibition test 
have been described in detail elsewhere (1). Phosphoribosyl pyrophosphate 
synthetase (PRPP synthetase, ribosephosphate pyrophosphokinase; EC 
2.7.6.1) activity was determined in cell extracts prepared as above with 1 mM 
dithiotreitol (DTT) added to the buffer and dialyzed for 12 h against 400 vol 
of the same buffer. PRPP synthetase activity was measured by a modification 
of the PRPP production assay described by Fox and Kelly (6). The reaction 
mixture contained cell extract (1-3 ~g protein), 50 mM potassium phosphate, 
pH 7.4, 0.5 mM DTT, 0.6 mM ribose 5-phosphate, 6 mM MgC12, 0.1 mM 
[8-~4C]adenine (6.5 mCi/mmol), and 100 #g of 90-fold purified human 
erythrocyte adenine phosphoribosyltransferase (PRPP synthetase-free) in a 
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final volume of 50 ~1. After 10 rain at 37~ the reaction was stopped by 
adding 10 ~1 of 0.2 M EDTA, and the products analyzed by high-voltage 
electropboresis (2). 
PRPP Assay. PRPP was determined in nondialyzed cell-free extracts. 
Logarithmically growing cells were washed twice in PBS, resuspended in 50 
mM potassium phosphate buffer, pH 7.4, containing 0.25 M sucrose and 1 
mM EDTA at 107 cells/ml, and lysed by freeze-thawing. The lysates were 
immediately immersed in boiling water for 1 rain, followed by centrifugation 
at 100,000g for 30 rain. Samples of the supernatant were dialyzed against 
three changes of 100 vol of extraction buffer for 1 h each to serve as 
PRPP-free controls. The rest of the extracts were kept at -70~ Reaction 
mixtures (50 #1) contained 50 mM potassium phosphate buffer, pH 7.4, 
5 mM MgC12, 20 #M [8-14C]hypoxanthine (11.2 #Ci/mmol), 0.5 ul of 
137-fold purified human erythrocyte HGPRT (4 ug protein, activity 3.7 x 
10 6 tool/h/rag protein), and 25 ul deproteinized cell extract. The reaction 
mixture was incubated for 60 rain at 37~ After incubation, 25 ul of each 
reaction mixture was spotted on a DEAE disk (Whatman DE81). The disks 
were air dried, washed twice in 1 mM ammonium formate, once in water, and 
finally in 95% ethanol. Subsequently, the disks were air dried, and 
radioactivity counted in a liquid scintillation counter. Under these conditions, 
100% and 98% of the hypoxanthine and PRPP added, respectively, were 
converted to IMP as measured by cellulose acetate electrophoresis by the 
method of Kizaki and Sakurada (7). 
Two-Dimensional Polyacrylamide Gel Electrophoresis. Two- 
dimensional potyacrylamide gel electrophoresis was performed as previously 
described (8) with some modifications. Approximately 108 cells were 
centrifuged at 500 g for 5 min. The cells were resuspended in 2 ml of 
Dulbecco's modified Eagle's medium containing 10% fetal bovine serum but 
no methionine and placed in 100-mm plastic petri plates. Each plate was 
immediately supplemented with 0.5 ml of the same medium containing 0.3 
mCi [35S]methionine (1.2 Ci/mmol). The cells were gently agitated every 
15-30 min during a 3-h incubation period. At the end of the incubation, the 
plates of cells were removed to a cold room, and all further operations were 
conducted at 0 to 4~ The cells were transferred to test tubes, washed twice 
with ice cold phosphate-buffered saline, and then suspended in 1.5 ml of 
extraction buffer (10 mM MgCI2, 30 mM KCI, 0.1 mM DTT, 0.5% Triton 
X-100, and 10 mM Tris HCI, pH7.4) and allowed to stand on ice for 5 min. 
The suspension was centrifuged at 19,000 g and the supernatant containing 
the HGPRT protein was stored in a liquid nitrogen freezer. Before use the 
thawed cell lysates were centrifuged for 2 h at 95,000 g and the high-speed 
supernatant fractions were subjected to electrophoresis or immunoprecipita- 
tion. 
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Immunoprecipitation of HGPRT Protein. Immunoprecipitation of 
HGPRT protein from cell extracts was a modification of the double-antibody 
procedure previously described (3, 8, 9). All Steps were performed at 0-4~ 
A 500-/A high-speed supernatant fraction sample of [35S]methioine-labeled 
cell extract (5 x 107 cpm) was mixed with 0.6 /xl HGPRT antibody and 
allowed to stand for 3-4 h. An equivalent of ralbbit anti-goat 3,-globulin serum 
(6 #1) was added and the mixture allowed to stand for an additional 5-8 h. 
The immunoprecipitate was sedimented by centrifugation for 10 rain at 
24,000 g. The precipitate was washed twice with extraction buffer containing 
0.5% sodium deoxycholate and either immediately dissolved in lysis buffer 
containing 9.5 M urea, 2% Triton X-100, 1.6% Bio-Rad Biolytes at pH 5-7, 
0.4% Biolytes at pH 3-10, and 5% 2-mercaptoethanol and applied to an 
isoelectric focusing gel as previously described (8), or stored in a liquid 
nitrogen freezer. Usually, one fifth of the immunoprecipitate was applied to 
an isoelectric focusing gel but greater amounts were used for mutant A29 
with low HGPRT cross-reacting material (1). 
RESULTS 
Heat Inactivation Studies. Cell extracts were incubated at 80~ for 
different times. Aliquots of the heat-treated extracts of A30 and wild-type L8 
cells were assayed for residual HGPRT activity, as well as for residual 
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Fig. 1. Thermal inactivation of HGPRT activity and antigenicity. Cell extracts containing 5 
mg/ml  protein were incubated at 80~ for different times, chilled in ice water, spun down, and 
the supernatant diluted and assayed for enzyme activity and CRM as described (1), except that 
A30 extracts were assayed for 1 h with 10 m M  PRPP. (A) HGPRT activity: The initial activity 
was 10,308 and 6576 cpm in the extracts of MGL8 and mutant A30, respectively. (B) 
Antigenicity: Same dilutions were used as in A. MGL8, 0 ;  A30, A. Bars represent standard 
errors. 
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Fig. 2. Autoradiogram of a two-dimensional polyacrylamide gel electrophoresis of extracts of the 
parental MGL8 cells. Cell proteins were labeled with [35S]methionine and extracts prepared as 
described in Materials and Methods. A sample of 20 30 ~I containing 100 150 #l protein and 
2-3 x 106 cpm of [35S]methionine was applied to isoelectric focusing gels with a pH 4-7 linear 
pH gradient, and run for 15-16 h at 400 V and an additional hour at 800 V. The gels were then 
exposed to the second-dimension separation of SDS slab gels. The dried gels were exposed to 
Kodak No-Screen medical x-ray film. Detailed description of the method was described in 
reference 8. Radioautographs are presented with isoelectric focusing pH 4 on the left, and pH 7 
on the right. The HGPRT spot is indicated by an arrow. 
amounts  of C R M  present  in the extracts  were plot ted agains t  incubat ion 
t ime,  and are  presented in Fig. 1A and B. The  loss of HGPRT-spec i f i c  
ant igenic i ty  in the cell extracts  as a result  of heat  t r ea tmen t  appears  to 
paral le l  the loss of ca ta ly t ic  activity.  
Analysis of CRM. A n  a u t o r a d i o g r a m  of  a t w o - d i m e n s i o n a l  
po lyacry lamide  gel e lectrophoresis  of  an ext rac t  of the paren ta l  M G L 8  cells is 
i l lus t ra ted in Fig. 2. The  spot corresponding to H G P R T  is indica ted  by an 
arrow. The  location of  the wi ld- type  H G P R T  is consis tant  with what  has been 
repor ted  for H e L a  cells and human e ry throcy te  H G P R T  (8, 9). The  H G P R T  
regions of the au to rad iograms  of M G L 8 ,  A30,  and A35 extracts  are  shown in 
Fig. 3A, B, and C, respectively.  The  HGPRT-d e f i c i en t  mutan t s  lack the 
wi ld- type  H G P R T  spot but  d isplay new spots, indica ted  by the arrows in Fig. 
3B and C. The  new H G P R T  spot of mu tan t  A35 coincides with another  
protein spot in the pat tern .  
Two-dimensional  separat ions  of the immunoprec ip i ta tes  from extracts  of 
the paren ta l  cells M G L 8  and the mu tan t  clones A30  and A35 are  shown in 
Fig. 4 A - E .  F igure  4A shows the au to rad iog ram of the immunoprec ip i t a t ed  
H G P R T  spot from the M G L 8  extract .  The  au to rad iograms  of mixtures  of the 
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Fig. 3. Autoradiogram of the HGPRT region from two dimensional gels of MGL8 and mutants 
A30 and A35 extracts: (A) MGLS; (B) A30; (C) A35. The HGPRT spots are indicated by 
arrows. A new spot in B, not present in the wild-type extracts, is indicated by an arrow head. 
immunoprecipitates of A30 and A35 with that of MGL8 are shown in Fig. 4B 
and C, respectively. The HGPRT spot of mutant A30 is shifted to a more 
basic isoelectric pH while that of mutant A35 is shifted to a more acidic 
isoelectric pH. The extract of mutant A29 displayed an immunoprecipitated 
spot of very low intensity at the same position as the wild-type protein (not 
shown). Extracts of A34, a CRM-negative mutant (1), showed no detectable 
cross-reacting HGPRT spot. 
The two-dimensional gel in Fig. 4B suggests that the spot corresponding 
to the A30 protein migrates faster than the wild-type protein in SDS 
polyacrylamide electrophoresis. To examine this further, immunoprecipitates 
of wild-type HPRT, A30 HPRT, and a mixture of wild-type and A30 HPRT 
proteins were subjected to one-dimensional  SDS polyacry lamide  
electrophoresis. The results are given in Fig. 5. The A30 HPRT protein 
migrates at an apparent molecular weight which is 400-1000 daltons less 
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Fig. 4. HGPRT region in two-dimensional polyacrylamide gel autoradiograph of immunoprecipi- 
tated (A) wild-type cell extract; (B) A30 cell extract; (C) A35 cell extract; (D) mixture of 
wild-type and A30 cell extracts; (E) mixture of wild-type and A35 cell extracts. Cell extracts 
containing [3SS]methionine-labeled proteins were reacted with goat anti-human HGPRT serum, 
followed by rabbit anti-goat 3,-globulin serum as described in Materials and Methods, and the 
immunoprecipitates were analyzed by two-dimensional electrophoresis. 
than the wild-type protein (determined by calibration with molecular-weight 
markers; data not shown). 
Degradation of HGPRT Protein. The gels were also stained for protein 
with Coomassie blue. The immunoprecipitates and extracts of mutant  A30, 
which give autoradiograms of comparable intensity to those of M G L 8  and 
A35, showed no H G P R T  protein in the Coomassie blue stained gels (not 
shown). Thus, the "specific radioactivity" of  the A30 H G P R T  is markedly 
higher. This suggested that  the rate of synthesis of the A30 enzyme is similar 
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Fig. 5. Size differences between MGL8 and A30 HGPRT CRM. Autoradiograph of SDS 
polyacrylamide gel of immunoprecipitated (A) A30 extract; (B) mixture of A30 and MGL8 
extracts; and (C) MGL8 extract. 
to that of the MGL8 HGPRT,  as indicated by the similar amounts of 
radiolabeled methionine incorporated during identical incubation periods. 
However, the rate of degradation of the A30 HGPRT is markedly higher 
than that of the MGL8 protein, resulting in a relatively high level of 
radioactivity in a small amount of protein. In contrast, the A35 HGPRT 
protein appeared to be synthesized and degraded at a similar rate to the 
MGL8 enzyme. 
It has been reported that abnormal proteins in general (10, 11), as well 
as abnormal mammalian HGPRT molecules specifically (12), are degraded 
preferentially. The rapid degradation of the A30 HGPRT apparent in the 
polyacrylamide gels is also manifested by the greater sensitivity to heat (Fig. 
1). 
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Table 1. Effect of PRPP on HGPRT activity" 
% of initial activity (SE) 
Incubation 
time Control Cells 1.0 mM PRPP 
MGL8 
A30 
0 100 100 
6 min 56 (0.1) 89.5 (0.5) 
12 min 40 (0.1) 88.0 (1.0) 
0 100 100 
20 sec 71.0 (1.0) 89.5 (0.5) 
60 sec 4.8 (0.3) 3.85 (0.25) b 
aCell extracts to which PRPP was added to a final concentration of 1 mM were incubated at 
80~ and the residual enzyme activity compared to samples heated without PRPP. The 
procedure and initial activities are identical to that described for Fig. 1. 
bThe difference is not significant at {he P _< 0.05 level. 
Stabilization by PRPP. It is known that  in the presence of P R P P  
H G P R T  activity shows marked resistance to inactivation by heat (13-15) .  
Since A30 H G P R T  has a very high Km for P R P P  (6 • 10 -2 compared with 3 
• 10 -5 for MGLS)  (1), we compared the stabilizing effect of P R P P  on 
enzyme activity and C R M  in the cell extracts. Table  1 summarizes the effects 
of PRPP  on the thermal  stability of H G P R T  activity in the MGL8 and A30 
extracts. While  the MGL8 enzyme was almost fully protected by 1 m M  
PRPP  against  inactivation by 80~ for up to 12 rain of incubation,  the 
H G P R T  activity in the A30 extracts was but  slightly protected and only 
during the first few seconds of incubation.  
The effects of P R P P  on the degradation of C R M  are similar to its effect 
on enzyme activity (Table  2). While  the M G L 8  enzyme protein was well 
protected, there was no protection of the A30 CRM.  The proteins from the 
two mutants  with no detectable catalytic activity, A35 and A29, were also not 
protected by PRPP.  Incidental ly,  Table  2 shows that while the A35 C R M ,  
like that  from the A29 and A30 mutants ,  is not protected by PRPP,  its rate of 
inactivation is not significantly higher than that  of the MGL8 enzyme. This is 
consistent with the two-dimensional  gel results discussed above. Compar ing 
Table 2. Effect of PRPP on CRM ~ 
% of initial CRM (SE) 
Incubation 
Cells time Control 1.0 mM PRPP 
MGL8 12 min 49.0 (1.0) 83.0 (0.1) 
A35 12 min 42.5 (4.5) b 44.0 (0.1) c 
A30 1 min 16.5 (1.5) 19.0 (0.1) c 
A29 1 min <5 <5 
"Cell extracts were incubated at 80~ as in Table 1. CRM was determined as described (1). 
bDifference between A35 and MGL8 is not significant. 
CNot significant at the P _< 0.05 level. 
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Table 3. PRPP synthetase activity and PRPP levels 
Cells 
MGL8 A29 A30 A35 
PRPP syn. activity (SE) 
(nmol/h/mg protein) 170.5 (16.5) 244 (26) 259 (26) 166.5 (6.5) 
PRPP levels (SE) 
(nmol/107 cells) 0,69 (0.03) - -  1.11 (0.2) - -  
the thermal inactivation of the A30 enzyme activity with the inactivation of 
its CRM (Fig. 1 and Tables 1 and 2) suggests that the enzyme activity of this 
mutant enzyme is more heat labile than the specific antigenic structure of the 
HGPRT molecule. 
PRPP Synthetase and PRPP Levels. The lack of protection by 1 mM 
PRPP of mutant HGPRT activity and CRM against inactivation by heat 
suggested that unless these cells have a markedly increased intracellular 
PRPP synthetase activity, and PRPP concentration, the lack of stabilization 
by PRPP could be the reason for the rapid degradation in vivo of the mutant 
HGPRT.  Therefore, we measured PRPP synthetase activity and PRPP levels 
in extracts of the parental MGL8 cells and mutants A29, A30, and A35. The 
enzyme activity found in A29 and A30 extracts was higher than the MGL8 
activity but only by 43 and 52%, respectively, and the cellular PRPP level of 
A30 cells was only 61% higher than that in the MGL8 cells (Table 3). 
DISCUSSION 
We have studied the HGPRT protein of three 6-TG-resistant mutants of 
the human lymphoblast cell line MGL8. Two of the CRM-positive mutants, 
namely A30 and A35, had structurally altered HGPRT protein, as is evident 
from the altered isoelectric pH. The molecular weight data in Fig. 5 suggest 
that A30 HGPRT protein is 3-9 amino acids shorter than the wild-type 
protein. The most likely explanation for an active protein with small deletion 
would be a chain-termination mutation near the carboxylterminus of the 
protein, i.e., the conversion of a code work for an amino acid near the end of 
the protein to one of those (UAA, UAG, or UGA) which code for protein 
chain termination during protein synthesis. The alteration in the isoelectric 
pH of A30 HGPRT protein would result if one of the amino acids deleted 
were glutamic or aspartic acid. The radioisotopic amino acid incorporation 
and peptide mapping techniques previously described (16) may permit 
confirmation of these predictions. 
While the immunoprecipitates of the enzyme of these two mutants gave 
autoradiogram spots of comparable intensity to that of the wild type, the 
Coomassie blue-stained gels of the A30 precipitate showed a very faint 
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protein spot containing all the radioactivity. This suggested that the A30 
H G P R T  is being synthesized at the same rate as the normal enzyme but is 
present in A30 cells in much lesser amounts. The low amount of CRM 
present in the A30 extracts is consistent with this interpretation (1). Cellular 
levels of protein are determined by the balance between the rates at which 
they are synthesized and degraded. In fact, selective degradation of abnormal 
proteins has been suggested as a protective mechanism against the intracellu- 
lar accumulation of physiologically defective molecules (17, 18). Cepacchi et 
al. (12) have studied selective degradation of mutant  H G P R T  molecules in a 
series of missense mutants of mouse L-cells. 
Our data regarding the thermal stability of C R M  suggests that two of 
the mutants, A29 and A30, contained H G P R T  protein which was more labile 
to heat than the wild-type enzyme, while the A35 C R M  showed no such 
difference. Comparison between the thermal inactivation of enzyme activity 
and of CRM in A30 extracts indicates that the former is more sensitive to 
heat than the latter. 
PRPP protected the normal enzyme of the parental MGL8 cells against 
the inactivation by heat of both enzyme activity and antigenicity. A30 
enzyme is only very slightly protected by the concentration of PRPP used 
( lmM) .  While A30 cells contain 61% more PRPP than wild-type cells, this 
increase would not protect A30 H G P R T  in view of its low recognition of 
PRPP as evidenced by a very high Km (1). It seems likely that lack of 
protection by PRPP, probably due to a change in the PRPP binding site, leads 
to rapid degradation and causes the low amounts of H G P R T  C R M  present in 
the A30 mutant cells. The low ratio of enzyme activity to C R M  in these cells 
(1) perhaps reflects the sequence of the degradation process of the mutant 
H G P R T  in which the loss of enzyme activity precedes the loss of antigenici- 
ty. 
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